Search research articles
Contact Us
Filters
Showing results (171-180 of 189) with videos related to
Page
of 19
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 11, 2026
Immune Spatial Organization Predicts Distant Metastasis Risk in Aggressive Localized Prostate Cancer
David D Yang, Aya Abdelnaser, Alexander J Haas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 3, 2017
Neoadjuvant Enzalutamide Prior to Prostatectomy
Bruce Montgomery, Maria S Tretiakova, Anthony M Joshua, et al.
Iscience
|
December 24, 2025
Developing therapeutic strategies to target MCL1 and BCLXL in lethal prostate cancer
Daniel Westaby, Juan M Jiménez-Vacas, Ines Figueiredo, et al.
Cell
|
July 28, 2009
Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer
Qianben Wang, Wei Li, Yong Zhang, et al.
European Urology
|
December 21, 2017
Role of Androgen Receptor Variants in Prostate Cancer: Report from the 2017 Mission Androgen Receptor Variants Meeting
Jun Luo, Gerhardt Attard, Steven P Balk, et al.
Cell Reports
|
May 31, 2025
BCL2 drives castration resistance in castration-sensitive prostate cancer by orchestrating reciprocal crosstalk between oncogenic pathways
Rahim Hirani, Subhiksha Nandakumar, Nabila Zaman, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 15, 2022
Inhibition of EZH2 transactivation function sensitizes solid tumors to genotoxic stress
Yiji Liao, Chen-Hao Chen, Tengfei Xiao, et al.
The Journal of Clinical Investigation
|
April 30, 2024
Androgen receptor splice variants drive castration-resistant prostate cancer metastasis by activating distinct transcriptional programs
Dong Han, Maryam Labaf, Yawei Zhao, et al.
Nature Communications
|
May 28, 2025
BH3 mimetics targeting BCL-XL have efficacy in solid tumors with RB1 loss and replication stress
Andreas Varkaris, Keshan Wang, Mannan Nouri, et al.
Cancer Discovery
|
March 10, 2017
Cabozantinib Eradicates Advanced Murine Prostate Cancer by Activating Antitumor Innate Immunity
Akash Patnaik, Kenneth D Swanson, Eva Csizmadia, et al.
Page
of 19
Search research articles
Search
Showing results (171-180 of 189) with videos related to
Sort By:
Page
of 19
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 11, 2026
Immune Spatial Organization Predicts Distant Metastasis Risk in Aggressive Localized Prostate Cancer
David D Yang, Aya Abdelnaser, Alexander J Haas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 3, 2017
Neoadjuvant Enzalutamide Prior to Prostatectomy
Bruce Montgomery, Maria S Tretiakova, Anthony M Joshua, et al.
Iscience
|
December 24, 2025
Developing therapeutic strategies to target MCL1 and BCLXL in lethal prostate cancer
Daniel Westaby, Juan M Jiménez-Vacas, Ines Figueiredo, et al.
Cell
|
July 28, 2009
Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer
Qianben Wang, Wei Li, Yong Zhang, et al.
European Urology
|
December 21, 2017
Role of Androgen Receptor Variants in Prostate Cancer: Report from the 2017 Mission Androgen Receptor Variants Meeting
Jun Luo, Gerhardt Attard, Steven P Balk, et al.
Cell Reports
|
May 31, 2025
BCL2 drives castration resistance in castration-sensitive prostate cancer by orchestrating reciprocal crosstalk between oncogenic pathways
Rahim Hirani, Subhiksha Nandakumar, Nabila Zaman, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 15, 2022
Inhibition of EZH2 transactivation function sensitizes solid tumors to genotoxic stress
Yiji Liao, Chen-Hao Chen, Tengfei Xiao, et al.
The Journal of Clinical Investigation
|
April 30, 2024
Androgen receptor splice variants drive castration-resistant prostate cancer metastasis by activating distinct transcriptional programs
Dong Han, Maryam Labaf, Yawei Zhao, et al.
Nature Communications
|
May 28, 2025
BH3 mimetics targeting BCL-XL have efficacy in solid tumors with RB1 loss and replication stress
Andreas Varkaris, Keshan Wang, Mannan Nouri, et al.
Cancer Discovery
|
March 10, 2017
Cabozantinib Eradicates Advanced Murine Prostate Cancer by Activating Antitumor Innate Immunity
Akash Patnaik, Kenneth D Swanson, Eva Csizmadia, et al.
Page
of 19